Aptahem AB (XSAT:APTA) Other Current Receivables : kr0.47 Mil (As of Jun. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Aptahem AB Other Current Receivables?

Aptahem AB's Other Current Receivables for the quarter that ended in Jun. 2024 was kr0.47 Mil.

Aptahem AB's quarterly Other Current Receivables increased from Dec. 2023 (kr0.38 Mil) to Mar. 2024 (kr0.69 Mil) but then stayed the same from Mar. 2024 (kr0.69 Mil) to Jun. 2024 (kr0.47 Mil).

Aptahem AB's annual Other Current Receivables increased from Dec. 2021 (kr0.24 Mil) to Dec. 2022 (kr0.49 Mil) but then declined from Dec. 2022 (kr0.49 Mil) to Dec. 2023 (kr0.38 Mil).

Aptahem AB Other Current Receivables Historical Data

The historical data trend for Aptahem AB's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptahem AB Other Current Receivables Chart

Aptahem AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Receivables

Get a 7-Day Free Trial

0.28

0.29

0.24

0.49

0.38

Aptahem AB Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Other Current Receivables	Get a 7-Day Free Trial															2.52	0.39	0.38	0.69	0.47

Aptahem AB Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Aptahem AB Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Aptahem AB's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptahem AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptahem AB (XSAT:APTA) » Definitions » Other Current Receivables

Comparable Companies

Traded in Other Exchanges

94V:Germany

Address

Norra Vallgatan 58, Malmo, SWE, 211 22

Website

http://www.aptahem.com

Aptahem AB develops aptamer-based drugs for the treatment of acute life-threatening conditions where coagulation and inflammation interact in the disease process. The company's main candidate Apta-1 is developed as an emergency medicine intended to prevent the occurrence of life-threatening organ and tissue damage in patients suffering from sepsis.

Aptahem AB Headlines

No Headlines